Irish Independent Normally anyone who buys classed growth clarets can expect to make a good return on their investment, or at least watch them hold their value. The Lynch Bages was bought for €58. If it goes to auction it can expect to make around €65. That's a profit ...
MedCity News “One of the things we see a lot of is combinations of chemotherapy and other drugs — it's more costly, the drug interactions can cause side effects and lead to secondary problems.” Forastiere added that white blood cell growth factor treatments that ... and more »
Irish Independent It forecasts between zero and 4pc earnings growth over the period, with large discrepancies between European-focused producers and more geographically diversified companies. It says the outlook for the sector is stable. The ratings agency says demand ... and more »
Motley Fool As you can guess from the fact that it's still using a code name, CO-1686 is a little further back in the clinic, but the data for the drug are having a la...
Doctors Lounge Cancers that develop resistance to anti-epidermal growth factor receptor treatments often have amplification of the MET gene, which can be targeted by ...
MarketWatch (press release) The paper's principal investigator, George Cotsarelis, MD, chair of Dermatology in the Perelman School of Medicine at the University of Penns...
pharmabiz.com Iniparib (BSI-201; SAR240550) is a benzamide (4-iodo-3-nitrobenzamide) that is structurally related to nicotinamide. Iniparib was initially designed as a poly (ADP-ribose) polymerase (PARP) 1 inhibitor based on the benzamide structure. Recent research ...
Medscape Patients were randomized to oral crizotinib 250 mg twice daily, or to chemotherapy with intravenous pemetrexed (500 mg/m²) or docetaxel (75 mg/m²) every 3 wee...
